ANTITRUST SUIT TAKES AIM AT THALIDOMIDE'S SECOND ACT City of Providence v. Celgene Corp. | Secondary Sources | Westlaw

ANTITRUST SUIT TAKES AIM AT THALIDOMIDE'S SECOND ACT City of Providence v. Celgene Corp. | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, ANTITRUST SUIT TAKES AIM AT THALIDOMIDE'S SECOND ACT City of Providence v. Celgene Corp., Secondary Sources
Skip Page Header

ANTITRUST SUIT TAKES AIM AT THALIDOMIDE'S SECOND ACT City of Providence v. Celgene Corp.

31 No. 2 WJPHAR 8By Michael Scott Leonard, Senior Legal Writer, Westlaw JournalsWestlaw Journal Pharmaceutical (Approx. 3 pages)

ANTITRUST SUIT TAKES AIM AT THALIDOMIDE'S SECOND ACT City of Providence v. Celgene Corp.

31 No. 2 WJPHAR 8By Michael Scott Leonard, Senior Legal Writer, Westlaw JournalsWestlaw Journal Pharmaceutical (Approx. 3 pages)

31 No. 2 Westlaw Journal Pharmaceutical 8
Westlaw Journal Pharmaceutical
*1 March 24, 2015
Thalidomide (Antitrust)
By Michael Scott Leonard, Senior Legal Writer, Westlaw Journals
Copyright © 2015 Thomson Reuters .

ANTITRUST SUIT TAKES AIM AT THALIDOMIDE'S SECOND ACT

City of Providence v. Celgene Corp.

Briefs and Other Related Documents
The capital city of Rhode Island has a filed an antitrust suit accusing Celgene Corp. of abusing decades-old distribution controls to prevent competitors from developing generic versions of thalidomide, a notorious morning-sickness drug now used to...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.